In-depth analysis of cervical cancer burden among gynecological malignancies at a tertiary cancer hospital, Hyderabad

https://doi.org/10.53730/ijhs.v6nS3.9262

Authors

  • K. Nirmala Department of Zoology, Research Scholar, Andhra University, Visakhapatnam
  • C. Manjulatha Department of Zoology, Andhra University, Visakhapatnam
  • K. Suseela MD, Senior Consultant & HOD, Pathology, BIACH & RI, Hyderabad

Keywords:

cervical cancer, prevalence, socioeconomic groups, stage of presentation

Abstract

Gynecologic malignancies are a major cause of morbidity and mortality worldwide. Understanding the most recent worldwide patterns and temporal changes in cervical cancer burden could help to prevent and control the disease. The goal of this retrospective study was to estimate the prevalence of cervical cancer among gynecological malignancies diagnosed at the Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI) Hyderabad, Telangana, India, between January 2017 and December 2021. This study received permission from the BIACH&RI's ethical committee. The information was manually obtained from clinical records based on each patient's MR numbers and the results were analyzed using a statistical package available from IBM SPSS version 26. During the study period of 5 years, a total of 94133 cases of various cancers were documented at BIACH&RI, among which 5524 were gynecological malignancies. The cervix was the most common site with 56%, followed by the ovary (26%) and endometrial (11.5%). Vulva and vaginal tumors were less frequent. According to this study cervical cancers occurred between 20-90 years with 61 percent of cases occurring in women aged 41 to 60. 

Downloads

Download data is not yet available.

References

Human papillomavirus (HPV) and cervical cancer. World Health Organization. 2020 Nov 11. URL: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer [accessed 2020-06-16]

Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575–90. https://doi.org/10.1016/S0140-6736(20)30068-4.

International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370(9599):1609–1621. [PubMed Abstract]

https://pubmed.ncbi.nlm.nih.gov/17993361/

Agarwal S, Malhotra KP, Rajaram S, Sinha S. Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade:Comparative evaluation with international data. Indian J Cancer. 2012;49(3):298–302. [PubMed] [Google Scholar]

https://pubmed.ncbi.nlm.nih.gov/23238148/

Afroz S, Ara G, Sultana F. Pattern of Gynecological Malignancies in a Tertiary Care Hospital. Open J Obstet Gynecol. 2019;9:449–457. [Google Scholar] https://www.scirp.org/journal/paperinformation.aspx?paperid=91700

India State-Level Disease Burden Initiative Cancer Collaborators. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol. 2018;19(10):1289–1306. https://doi.org/10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12. Erratum in: Lancet Oncol. 2018 Oct 3;: PMID: 30219626; PMCID: PMC6167407.

Institute for Health Metrics and Evaluation. The Challenge Ahead: Progress in Breast and Cervical Cancer. Institute of Health Metrics and Evaluation. 2011. [Last accessed on 2016 Jan 21]. https://www.healthdata.org/policy-report/challenge-ahead-progress-and-setbacks-breast-and-cervical-cancer

Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low– and middle-income developing countries. Bull World Health Organ. 2001;79:954–62. https://pubmed.ncbi.nlm.nih.gov/11693978/

Epidemiology of cervical cancer with special focus on India Aswathy Sreedevi, Reshma Javed, and Avani Dinesh https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404964/

Burden of cervical cancer and role of screening in India

Saurabh Bobdey, Jignasa Sathwara, [...], and Ganesh Balasubramaniam

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234166/

Pattern of gynaecological malignancies at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Ibrahim HM, Ijaiya MA.J Obstet Gynaecol. 2013 Feb;33(2):194-6. doi: 10.3109/01443615.2012.738717. PMID: 23445148 https://pubmed.ncbi.nlm.nih.gov/23445148/

FEMALE GENITAL TRACT CANCERS IN SAGAMU, SOUTHWEST, NIGERIA. Adefuye PO, Adefuye BO, Oluwole AA.East Afr Med J. 2014 Nov;91(11):398-406.PMID: 26866088 https://pubmed.ncbi.nlm.nih.gov/26866088/

Genital tract malignancies in postmenopausal women.

Khursheed F, Jatoi N, Das CM.J Ayub Med Coll Abbottabad. 2010 Jul-Sep;22(3):32-4.PMID: 22338412 https://pubmed.ncbi.nlm.nih.gov/22338412/

Spectrum of Gynecological Malignancies at Jamshoro.

Parveen N, Sikander R, Majida, Shaheen.J Coll Physicians Surg Pak. 2018 Jan;28(1):52-55.PMID: 29290193 https://pubmed.ncbi.nlm.nih.gov/29290193/,

Gynecological malignancies in Aminu Kano Teaching Hospital Kano: a 3 year review.Yakasai IA, Ugwa EA, Otubu J.Niger J Clin Pract. 2013 Jan-Mar;16(1):63-6. doi: 10.4103/1119-3077.106768.PMID: 23377473 https://pubmed.ncbi.nlm.nih.gov/23377473/

Pattern of gynaecological cancers in University of Nigeria Teaching Hospital, Enugu, south eastern Nigeria. Ugwu EO, Iferikigwe ES, Okeke TC, Ugwu AO, Okezie OA, Agu PU.Niger J Med. 2011 Apr-Jun;20(2):266-9.PMID: 21970241 https://pubmed.ncbi.nlm.nih.gov/21970241/,

Malignant tumours of the genital tract among Batswana women.

Tanko MN, Kayembe MA, Cainelli F, Vento S.Ghana Med J. 2012 Sep;46(3):142-6.PMID: 23661827 https://pubmed.ncbi.nlm.nih.gov/23661827/

Role of Hospital-Based Cancer Registries: A Decade of Experience of Cancer Cervix from a Tertiary Care Centre, India

Shalini Rajaram, Sruthi Bhaskaran, [...], and Sarla Agarwal

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215506/

Gynecological malignancies at tertiary care hospital, Pakistan: A five-year review.Wasim T, Mushtaq J, Wasim AZ, Raana GE.Pak J Med Sci. 2021 May-Jun;37(3):621-627. doi: 10.12669/pjms.37.3.3596.PMID: 34104137

https://pubmed.ncbi.nlm.nih.gov/34104137/,

Pattern of gynaecological malignancies in south western region of Pakistan: An overview of 12 years. Manzoor H, Naheed H, Ahmad K, Iftikhar S, Asif M, Shuja J, Sultan N, Ali I, Inayatullah S, Khan YH.Biomed Rep. 2017 Nov;7(5):487-491. doi: 10.3892/br.2017.993. Epub 2017 Sep 28.PMID: 29109863 https://pubmed.ncbi.nlm.nih.gov/29109863/

A heartrending burden of gynaecological cancers in advance stage at nuclear institute of medicine and radiotherapy Jamshoro Sindh.

Bibi S, Ashfaque S, Laghari NA.Pak J Med Sci. 2016 Jan-Feb;32(1):120-4. doi: 10.12669/pjms.321.8663.PMID: 27022358 https://pubmed.ncbi.nlm.nih.gov/27022358/

Gynaecological Malignancies Among a Representative Population of Batticaloa, Sri Lanka.

Thirukumar M, Sinnathurai A.Cureus. 2021 Jan 27;13(1):e12947. doi: 10.7759/cureus.12947.PMID: 33654623 https://pubmed.ncbi.nlm.nih.gov/33654623/

A Review of Cervical Cancer: Incidence and Disparities

Author links open overlay panelAmaBuskwofieM.D.abGizelkaDavid-WestM.D.abCamille A.ClareM.D., M.P.H. https://www.sciencedirect.com/science/article/abs/pii/S0027968420300432

Tanko NM, Echejoh GO, Manasseh AN, Mandong BM, Banwat EB, Daru PH. Cervical dysplasia in HIV seropositive women in Nigeria. Highland Medical Research Journal. 2006;4:21–26. [Google Scholar] https://www.ajol.info/index.php/hmrj/article/view/33908

Fayo-Ndao MA, Diack-Mbaye A, Woto Gaye G. Cervical dysplasia in HIV infection in Senegal; Int Conf Aids; July 19–22, 1992; (8th International AIDS Conference Amsterdam) [Google Scholar] https://www.africabib.org/rec.php?RID=W00074298

Chirenze ZM. Association of cervical squamous intraepithelial and HIV-1 infection among Zimbabwean women in HIV/STI prevention centre. Int Journal of STD and AIDS. 2002;13:765–768. [PubMed] [Google Scholar]

https://pubmed.ncbi.nlm.nih.gov/12437897/

Walboomers JMM, Jacobs MV, Manos MM, Bosch FX. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1997;189:12–19. [PubMed] [Google Scholar] https://pubmed.ncbi.nlm.nih.gov/10451482/

World Health Organization call for action to eliminate cervical cancer globally. Gultekin, Murat; Ramirez, Pedro T; Broutet,athalie; Hutubessy, Raymond.https://www.proquest.com/openview/9883ebd14b5e9b6725854758d2af99e7/1?pq-origsite=gscholar&cbl=5161120)

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts Renga swamy Sankara narayanan MD, Partha Basu MD, Prabhdeep Kaur DNB, Rajesh Bhaskar MD, Gurinder Bir Singh MD, Phumzay Denzongpa MBBS, Prof Rajesh K Grover MD, Paul Sebastian MD, Tapan Saikia MD, Kunal Oswal MPH, Rishav Kanodia PGDM, Amantia Dsouza MSc, Ravi Mehrotra DPhil, Prof.Goura Kishor Rath MD Viniita Jaggi MD Sundram Kashyap MD, Ishu Kataria PhD, Roopa Hariprasad DGO….Prof.Arnie Purushotham MD https://www.sciencedirect.com/science/article/abs/pii/S1470204519305315

Agosti Jan M, Sue J, Goldie Jan M. Introducing HPV vaccine in developing countries—key challenges and issues. N Engl J Med. 2007; 356:1908–1910. doi:10.1056/NEJMp078053.[PubMed] [Google Scholar]

https://pubmed.ncbi.nlm.nih.gov/17494923/

Pattern of presentation of cervical carcinoma at Nuclear Institute of Medicine and Radiotherapy, Pakistan. Aziz N, Yousfani S.Pak J Med Sci. 2013 May;29(3):814-7.PMID: 24353634

https://pubmed.ncbi.nlm.nih.gov/24353634/

Aniebue UU, Onyeka TC. Ethical, Socioeconomic, and Cultural Considerations in Gynecologic Cancer Care in Developing Countries. Int J Palliative Care. 2014. 2014 doi:10.1155/2014/141627. [Google Scholar]

https://www.hindawi.com/journals/ijpc/2014/141627/

Unger-Saldaña K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014; 5(3): 465. doi:10.5306%2Fwjco.v5.i3.465. [PMC free article] [Pub Med] [Google Scholar] https://pubmed.ncbi.nlm.nih.gov/25114860/

Blumenthal PD, Lauterbach M, Sellors JW, Sankaranarayanan R. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynecol Obstetr. 2005;89:S30–S37. doi:10.1016/j.ijgo.2005.01.012. [PubMed] [Google Scholar] https://pubmed.ncbi.nlm.nih.gov/15823264/

Published

18-06-2022

How to Cite

Nirmala, K., Manjulatha, C., & Suseela, K. (2022). In-depth analysis of cervical cancer burden among gynecological malignancies at a tertiary cancer hospital, Hyderabad. International Journal of Health Sciences, 6(S3), 9980–9994. https://doi.org/10.53730/ijhs.v6nS3.9262

Issue

Section

Peer Review Articles